サイクロフィリンD阻害剤のパイプライン・インサイト2019

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2016216)
◆英語タイトル:Cyclophilin D Inhibitors -Pipeline Insights, 2019
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2016216
◆発行日:2020年05月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[サイクロフィリンD阻害剤のパイプライン・インサイト2019]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるサイクロフィリンD阻害剤のパイプライン動向について調査・分析し、以下の構成でお届けいたします。

・サイクロフィリンD阻害剤の概要
・サイクロフィリンD阻害剤のパイプライン概要
・企業別開発中のサイクロフィリンD阻害剤
・後期治験段階の薬剤(Filed & Phase III):比較分析
・中期治験段階の薬剤(Phase II):比較分析
・初期治験段階の薬剤(Phase I & IND Filed):比較分析
・薬剤候補のプロファイル
・サイクロフィリンD阻害剤の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価
・開発が中止された薬剤リスト
・開発休止中の薬剤リスト
・サイクロフィリンD阻害剤開発に取り組んでいる企業リスト
・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “Cyclophilin D Inhibitors-Pipeline Insights, 2019”, report provides in depth insights on the pipeline drugs and their development activities around the Cyclophilin D Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Cyclophilin D Inhibitors. DelveInsight’s Report also assesses the Cyclophilin D Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitive pipeline landscape of Cyclophilin D Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Cyclophilin D Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Cyclophilin D Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Cyclophilin D Inhibitors Overview
• Cyclophilin D Inhibitors Disease Associated
• Cyclophilin D Inhibitors Pipeline Therapeutics
• Cyclophilin D Inhibitors Therapeutics under Development by Companies
• Cyclophilin D Inhibitors Filed and Phase III Products
• Comparative Analysis
• Cyclophilin D Inhibitors Phase II Products
• Comparative Analysis
• Cyclophilin D Inhibitors Phase I and IND Filed Products
• Comparative Analysis
• Cyclophilin D Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Cyclophilin D Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Cyclophilin D Inhibitors – Discontinued Products
• Cyclophilin D Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Cyclophilin D Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Cyclophilin D Inhibitors by Therapy Area, 2019
• Number of Products under Development for Cyclophilin D Inhibitors, 2019
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2019
• Comparative Analysis Phase II Products, 2019
• Comparative Analysis Phase I and IND Filed Products, 2019
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2019
• Drug Candidates Profiles
• Cyclophilin D Inhibitors Assessment by Monotherapy Products
• Cyclophilin D Inhibitors Assessment by Combination Products
• Cyclophilin D Inhibitors Assessment by Route of Administration
• Cyclophilin D Inhibitors Assessment by Stage and Route of Administration
• Cyclophilin D Inhibitors Assessment by Molecule Type
• Cyclophilin D Inhibitors Assessment by Stage and Molecule Type
• Cyclophilin D Inhibitors Therapeutics – Discontinued Products
• Cyclophilin D Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2019


List of Figures
• Number of Products under Development for Cyclophilin D Inhibitors by Therapy Area, 2019
• Number of Products under Development for Cyclophilin D Inhibitors, 2019
• Filed and Phase III Products, 2019
• Phase II Products, 2019
• Phase I and IND Filed Products, 2019
• Discovery and Pre-Clinical Stage Products, 2019
• Cyclophilin D Inhibitors Assessment by Monotherapy Products
• Cyclophilin D Inhibitors Assessment by Combination Products
• Cyclophilin D Inhibitors Assessment by Route of Administration
• Cyclophilin D Inhibitors Assessment by Stage and Route of Administration
• Cyclophilin D Inhibitors Assessment by Molecule Type
• Cyclophilin D Inhibitors Assessment by Stage and Molecule Type


*** レポートのキーワード ***

サイクロフィリンD阻害剤、医薬品、製薬、研究開発、パイプライン、治療、治験

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 個人用増音器の世界及び中国市場 2018年
    The 'Global and Chinese Personal Sound Amplifier Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Personal Sound Amplifier industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pe …
  • 油性インクの世界及び中国市場 2018年
    The 'Global and Chinese Solvent Based Inks Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Solvent Based Inks industry with a focus on the Chinese market. The report provides key statistics on the market status of the Solvent Based …
  • 産業カルーセルシステムの世界市場予測2018-2023
    A carousel is an automated storage and retrieval device using a series of shelving units mounted on a closed-loop track. Carousels are one of the fastest, most efficient technologies available for picking, packing and order fulfillment operations. These high-density storage devices save space and in …
  • 月経困難症治療薬の世界市場:市場インサイト、疫学、市場予測
    Note*: This report requires 5-10 business days to complete. DelveInsight’s Dysmenorrhea - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Ge …
  • ニッケル系OCTGの世界市場2018
    Nickel Based OCTG Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germ …
  • 自動車用ヒューマンマシンインタフェース(HMI)の世界市場2016-2020
    About Automotive Human Machine Interface Automotive HMI systems are used to manage diverse vehicle and infotainment features. These systems are efficient in warning the drivers regarding upcoming problems on the road or within the vehicle. Additionally, they provide improved comfort and assistance t …
  • デジタル印刷及び染色機の世界市場2017-2021
    About Digital Printing and Dyeing MachinesThe global digital printing and dyeing machines market is highly dependent on the global textile trade dynamics. The growing global population coupled with improving economic conditions is a major driver that is likely to increase the appetite for essential …
  • 市中感染:治験レビュー2019年上半期
    Community-Acquired Infections Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, “Community-Acquired Infections Global Clinical Trials Review, H1, 2019" provides an overview of Community-Acquired Infections clinical trials scenario. This report provides top line data …
  • 毒性試験の世界市場 2019年-2023年
    In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Toxicology Testing Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regio …
  • 世界のNMOSイメージセンサ市場2017
    Notes:Sales, means the sales volume of NMOS Image Sensors Revenue, means the sales value of NMOS Image Sensors This report studies sales (consumption) of NMOS Image Sensors in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2016216 )"サイクロフィリンD阻害剤のパイプライン・インサイト2019" (英文:Cyclophilin D Inhibitors -Pipeline Insights, 2019)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。